Lichenoid cutaneous drug reaction at injection sites of granulocyte colony-stimulating factor (Filgrastim)

Dermatology. 1999;198(3):301-3. doi: 10.1159/000018136.

Abstract

Colony-stimulating factors are widely used for bone marrow recovery after chemotherapy. Various cutaneous side-effects have been described in most cases involving neutrophils. We report the first case of lichenoid reaction at injection sites of granulocyte colony-stimulating factor (G-CSF) in a 40-year-old patient treated for breast cancer. The eruption cleared after drug withdrawal, no recurrence was observed after drug replacement by granulocyte-macrophage colony-stimulating factor. Mainly lymphocyte-mediated lichenoid eruption to G-CSF was shown. Cutaneous side-effects to G-CSF do not share unequivocal pathogeny based on stimulation of neutrophils.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Breast Neoplasms / drug therapy
  • Drug Eruptions / etiology*
  • Female
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / adverse effects*
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Humans
  • Injections
  • Lichenoid Eruptions / chemically induced*
  • Recombinant Proteins
  • Skin / drug effects*
  • Skin / pathology

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Filgrastim